Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 jul 2013 - 07:34
Statutaire naam
Galapagos NV
Titel
Galapagos delivers novel osteoarthritis molecules in alliance with Servier
Bericht
Mechelen, Belgium; 23 July 2013 - Galapagos NV (Euronext: GLPG) announced today the achievement of a late stage discovery milestone for small molecules against a novel target in the osteoarthritis (OA) alliance with Servier. This milestone triggered a payment to Galapagos of €3 million and will contribute to Group revenues in the first half of 2013.
Datum laatste update: 21 december 2025